Multiple conformations of 5-HT2A and 5-HT2C receptors in rat brain: an autoradiographic study with [125I](±)DOI

[1]  B. Roth,et al.  Antagonist Functional Selectivity: 5-HT2A Serotonin Receptor Antagonists Differentially Regulate 5-HT2A Receptor Protein Level In Vivo , 2011, Journal of Pharmacology and Experimental Therapeutics.

[2]  M. Loza,et al.  Evidence for Distinct Antagonist-Revealed Functional States of 5-Hydroxytryptamine2A Receptor Homodimers , 2009, Molecular Pharmacology.

[3]  G. Kennett,et al.  Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  M. Loza,et al.  Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists. , 2001, Molecular pharmacology.

[5]  V. Arango,et al.  In vitro autoradiography of serotonin 5‐HT2A/2C receptor‐activated G protein: Guanosine‐5′‐(γ‐[35S]thio)triphosphate binding in rat brain , 2000, Journal of neuroscience research.

[6]  B. Roth,et al.  Agonist high and low affinity state ratios predict drug intrinsic activity and a revised Ternary complex mechanism at serotonin 5‐HT2A and 5‐HT2C receptors , 2000, Synapse.

[7]  P. Strange.  G-protein coupled receptors: conformations and states. , 1999, Biochemical pharmacology.

[8]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[9]  S. Maayani,et al.  Pleiotropic Behavior of 5‐HT2A and 5‐HT2C Receptor Agonists , 1998, Annals of the New York Academy of Sciences.

[10]  J. Harvey,et al.  Agonist and Antagonist Binding to Rabbit Cortical 5‐HT2A Receptors: Opposite Effects of Magnesiuma , 1998 .

[11]  M. Teitler,et al.  Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[12]  P. Strange.  Three-state and two-state models. , 1998, Trends in pharmacological sciences.

[13]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[14]  A. Brown,et al.  SB 242084, a Selective and Brain Penetrant 5-HT2C Receptor Antagonist , 1997, Neuropharmacology.

[15]  B. Roth,et al.  High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model. , 1997, The Journal of pharmacology and experimental therapeutics.

[16]  J. Northup,et al.  Functional Reconstitution in Situ of 5-Hydroxytryptamine2c (5HT2c) Receptors with αq and Inverse Agonism of 5HT2c Receptor Antagonists* , 1996, The Journal of Biological Chemistry.

[17]  Hans Förstl,et al.  Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.

[18]  J. Kehne,et al.  Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. , 1996, The Journal of pharmacology and experimental therapeutics.

[19]  T. Kenakin,et al.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.

[20]  F. Blaney,et al.  5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.

[21]  D. Wright,et al.  Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain , 1995, The Journal of comparative neurology.

[22]  E. sanders-Bush,et al.  Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. , 1994, Molecular pharmacology.

[23]  J. Palacios,et al.  Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. , 1994, Brain research. Molecular brain research.

[24]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[25]  E. sanders-Bush,et al.  Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. , 1994, The Journal of biological chemistry.

[26]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[27]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[28]  J. Launay,et al.  New mouse 5‐HT2‐like receptor Expression in brain, heart and intestine , 1992, FEBS letters.

[29]  B. Hoffman,et al.  Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. , 1992, Molecular pharmacology.

[30]  H. Kao,et al.  [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. , 1990, Molecular pharmacology.

[31]  B. Hoffman,et al.  4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes. , 1990, Molecular pharmacology.

[32]  R. Glennon,et al.  Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.

[33]  S. Peroutka,et al.  Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R- (-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  S. Peroutka,et al.  Evidence for Distinct 5‐Hydroxytryptamine2 Binding Site Subtypes in Cortical Membrane Preparations , 1989, Journal of neurochemistry.

[35]  D. E. Nichols,et al.  Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand , 1989, Brain Research.

[36]  C. Mathis,et al.  Binding to the serotonin 5-HT2 receptor by the enantiohers of 125I-DOI , 1987, Neuropharmacology.

[37]  C. Mathis,et al.  Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain. , 1987, European journal of pharmacology.

[38]  J. Palacios,et al.  Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites , 1986, Brain Research.

[39]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[40]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[41]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[42]  L. Tecott,et al.  Serotonin 2C receptor knockout mice: Autoradiographic analysis of multiple serotonin receptors , 2002, Journal of neuroscience research.

[43]  R. Glennon,et al.  Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  J. Harvey,et al.  Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium. , 1998, Annals of the New York Academy of Sciences.

[45]  B. Roth,et al.  Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. , 1998, Critical reviews in neurobiology.

[46]  R. Glennon,et al.  [125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors. , 1988, Journal of medicinal chemistry.

[47]  R. Glennon,et al.  Iodine-125 labeled 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors , 1988 .